Terms search
1

Handelsgesetzbuch: Band 7 §§ 316-324a
Mathias Habersack; Christoph Weber
2

Handelsgesetzbuch: Band 7 §§ 316-324a
Mathias Habersack; Christoph Weber
3

Die Normativität des Rechts bei Francisco de Vitoria
Kirstin Bunge; Anselm Spindler; Andreas Wagner (Hrsg.)
4

Francisco de Vitorias "De Indis" in interdisziplinärer Perspektive
Norbert Brieskorn; Gideon Stiening (Hrsg.)
5

The Concept of Just War in Judaism, Christianity and Islam
Georges Tamer (editor); Katja Thörner (editor)
6

From Just War to Modern Peace Ethics
Heinz-Gerhard Justenhoven (editor); William A. Barbieri Jr. (editor)
7

The Concept of Just War in Judaism, Christianity and Islam
Georges Tamer; Katja Thörner
8

Aspects of China's new role in the globalized world: problems of international politics
Zhong nan da xue; Günther; Hans-Christian; Sun; Chan
9

TheCYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer
Christina Justenhoven; Christiane B. Pierl; Susanne Haas; Hans-Peter Fischer; Christian Baisch; Ute Hamann; Volker Harth; Beate Pesch; Thomas Brüning; Caren Vollmert; Thomas Illig; Jürgen Dippon; Yon-
10

No evidence for glutathione S-transferasesGSTA2,GSTM2,GSTO1,GSTO2, andGSTZ1in breast cancer risk
Irena E. Andonova; Christina Justenhoven; Stefan Winter; Ute Hamann; Christian Baisch; Sylvia Rabstein; Anne Spickenheuer; Volker Harth; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Varban Ganev; Hiltr
11

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying theCYP2C19*17 variant
Christina Justenhoven; Ofure Obazee; Stefan Winter; Fergus J. Couch; Janet E. Olson; Per Hall; Ulf Hannelius; Jingmei Li; Keith Humphreys; Gianluca Severi; Graham Giles; Melissa Southey; Laura Bagliet
12

Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk
Christina Justenhoven; Elke Schaeffeler; Stefan Winter; Christian Baisch; Ute Hamann; Volker Harth; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Matthias Schwab; Hil
13

Polymorphisms in theUBC9andPIAS3genes of the SUMO-conjugating system and breast cancer risk
Thomas Dünnebier; Justo Lorenzo Bermejo; Susanne Haas; Hans-Peter Fischer; Christiane B. Pierl; Christina Justenhoven; Hiltrud Brauch; Christian Baisch; Michael Gilbert; Volker Harth; Anne Spickenheue
14

Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors
Christina Justenhoven; Christiane B. Pierl; Susanne Haas; Hans-Peter Fischer; Ute Hamann; Christian Baisch; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Caren Vollmert; Thomas Illig; Beate Pesch;
15

Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: A population-based case–control study and meta-analyses
Jolanta Lissowska; Mia M. Gaudet; Louise A. Brinton; Stephen J. Chanock; Beata Peplonska; Robert Welch; Witold Zatonski; Neonila Szeszenia-Dabrowska; Sue Park; Mark Sherman; Montserrat Garcia-Closas
16

The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors
Christina Justenhoven; Stefan Winter; Ute Hamann; Susanne Haas; Hans-Peter Fischer; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Hiltrud Brauch; for the GENICA Network
17

The earwax-associated SNP c.538G>A (G180R) inABCC11is not associated with breast cancer risk in Europeans
Thomas Lang; Christina Justenhoven; Stefan Winter; Christian Baisch; Ute Hamann; Volker Harth; Yon-Dschun Ko; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Matthias Schwab; Hiltrud
18

No association of polymorphisms in the cell polarity geneSCRIBwith breast cancer risk
Thomas Dünnebier; Klaus Schlaefer; Michael Gilbert; Christian Baisch; Christina Justenhoven; Hiltrud Brauch; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Beate Pesch; Thomas Brüning; Yon-Dschun K
19

Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls
Xiangyu Ma; Xiaowei Qi; Chunhai Chen; Hui Lin; Hongyan Xiong; Yafei Li; Jun Jiang
20

CYP2C19*17 is associated with decreased breast cancer risk
Christina Justenhoven; Ute Hamann; Christiane B. Pierl; Christian Baisch; Volker Harth; Sylvia Rabstein; Anne Spickenheuer; Beate Pesch; Thomas Brüning; Stefan Winter; Yon-Dschun Ko; Hiltrud Brauch
21

CombinedUGT1A1andUGT1A6genotypes together with a stressful life event increase breast cancer risk
Christina Justenhoven; Stefan Winter; Thomas Dünnebier; Ute Hamann; Christian Baisch; Sylvia Rabstein; Anne Spickenheuer; Volker Harth; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Hiltrud Brauch
22

MALDI-TOF MS and TaqMan® assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET)
Malgorzata Jaremko; Christina Justenhoven; Benny K. Abraham; Werner Schroth; Peter Fritz; Sandra Brod; Caren Vollmert; Thomas Illig; Hiltrud Brauch
23

Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls
Theodoros N. Sergentanis; Konstantinos P. Economopoulos
24

Test of Hardy–Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions
Ke-Da Yu; Geng-Hong Di; Lei Fan; Zhi-Ming Shao
25

No evidence thatGATA3rs570613 SNP modifies breast cancer risk
Sharon E. Johnatty; Fergus J. Couch; Zachary Fredericksen; Robert Tarrell; Amanda B. Spurdle; Jonathan Beesley; Xiaoqing Chen; kConFab Investigators; AOCS Group; The Swedish BRCA1 and BRCA2 Study Coll
26

TheCASP8-652 6N del promoter polymorphism and breast cancer risk: a multicenter study
Bernd Frank; Sushila H. Rigas; Justo Lorenzo Bermejo; Miriam Wiestler; Kerstin Wagner; Kari Hemminki; Malcolm W. Reed; Christian Sutter; Barbara Wappenschmidt; Sabapathy P. Balasubramanian; Alfons Mei
27

The role of ERCC2 polymorphisms in breast cancer risk
Susana N. Silva; Guilherme Bezerra de Castro; Ana Faber; Marcelo Pires; Vanessa C. Oliveira; Ana Paula Azevedo; Marisa N. Cabral; Isabel Manita; Julieta Esperança Pina; José Rueff; Jorge Gaspar
28

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
Li-Xin Qiu; Lei Yao; Jian Zhang; Xiao-Dong Zhu; Xin-Min Zhao; Kai Xue; Chen Mao; Bo Chen; Ping Zhan; Hui Yuan; Xi-Chun Hu
29

The association between two polymorphisms in the TYMS gene and breast cancer risk: appraisal of a recent meta-analysis
Yan-Feng Zou; Fang Wang; Xiao-Liang Feng
30

Inspection of a deviation from Hardy–Weinberg equilibrium in familial breast cancer cases from a case–control study in a meta-analysis
Ke-Da Yu; Zhi-Ming Shao
31

No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population
Chun Zhang; Ping Zhou; Jian-Ping Li
32

Erratum to: Postmenopausal estrogen monotherapy–associated breast cancer risk is modified byCYP17A1_-34_T>C polymorphism
The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk